Omnia Education

Extended Genotyping: Informing Risk Stratification and More Personalized Care

This article discusses extended HPV genotyping tests and their role in risk stratification of HPV positive women.

Available credits: 0.50

Time to complete: 30 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    HPV genotyping is an important tool for risk stratification of HPV positive women since HPV 16/18 account for approximately 70% of invasive cervical cancers and HPV 16 positive women have a greatly elevated risk of being diagnosed with CIN3+ over the following decade compared to women with other high-risk HPV genotypes.

  • Disclosure of Conflicts of Interest

    Disclosure of Conflicts of Interest:
    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty:
    Thomas C. Wright, Jr., MD
    Professor Emeritus of Pathology and Cell Biology
    Columbia University
    New York, New York

    Financial Disclosure:
    Dr. Wright has disclosed that he is a consultant for Roche Molecular Systems, and Ventana and is on the speakers’ bureau for BD Diagnostics and Cepheid.

    Reviewers/Planners/Authors:
    • Sean T. Barrett has nothing to disclose.
    • Kenneth Brown has nothing to disclose.
    • Barry A. Fiedel, PhD has nothing to disclose.
    • Kia K. Gray, MPH has nothing to disclose.

  • Learning Objectives

    • Differentiate when it is appropriate to integrate co-testing and primary HPV testing or chose one over the other when managing HPV+ women
    • Decide which high-risk genotypes are important for management
    • Determine which algorithms to use and how to incorporate genotyping into cervical cancer screening
    • Identify cases where expanded genotyping could potentially be used
  • Target Audience

    This activity is designed to meet the educational needs of obstetricians, gynecologists, primary care physicians, nurse practitioners, physician assistants, and certified nurse-midwives.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Omnia Education has a core focus on women's health and the ways in which diseases and conditions impact the female patient. That unique focus has transformed the CME learning environment for healthcare professionals nationwide. We impact thousands of clinicians annually, many of whom return each year for clinical updates and connectivity with regional peers.

  • Commercial Support

    This activity is supported by an independent educational grant from BD Life Sciences. 

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

Sign-up for the Omnia Education newsletters.
Comprehensive women’s health CME.

Better education for a better you.

* Required
Optional